Aalsmeer, Netherlands
Role of biomarkers in advancing access to treatments for individuals with neurocognitive or neuronopathic MPS conditions
Hosted by MPS Society in association with IMPSN, this event aims to bring clinical & scientific experts together with decision makers, industry & patient organisations to highlight the importance of integrating biomarkers into regulatory frameworks.
Find out more